Yesterday Novo Nordisk announced they were expanding their partnership with Flex Digital Health. Per a story on the FireceBiotech web site;
“Novo Nordisk has tapped Flex Digital Health’s internet of things platform to create new digital tools for people with diabetes. The duo previously teamed up on connected insulin pens, two of which are slated to launch early next year.
Their existing partnership focuses on building connectivity into devices, such as nonconnected insulin pens, so that patients and physicians can see exactly which insulin a patient takes, at what dose and when the patient administered it.”
It seems that . . .
This content is restricted to subscribers. Please subscribe.
Already have an account? Please login.